Program Suspension is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2015. All patents have expired. Details of Program Suspension’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5776982 | Active | |
About Program Suspension
Program Suspension is a drug
owned by ELANCO US INC.
Program Suspension uses
Lufenuron as the active
ingredient.
Active Ingredient:
Program Suspension uses
Lufenuron as the active ingredient.
Check out other Drugs and Companies using
Lufenuron ingredient.